A. I. Tailored Personalized Information for your Specific Industry or Condition State
Investor Contact
We are seeking a Business Partner, eager to become
the world’s leading authority in the regulated industry, in what will be a $30 million plus, annual recuring revenue.
In 2026 www.fda.com will be launching the largest ‘Private’ Association dedicated to the Pharmaceutical, Clinical, Medical Device, Cosmetics, Dietary Supplements, including News & Announcements from the Medical industry for both Consumers and Business Professionals.
Watch the Video Explaining the Capabilities.
The site is www.fda.com
(currently accessible at www.fdademo.com).
Call 609-217-7031 to Arrange a Demo!
We expect over 1 million members by the end of 2026 with over 5 million by the end of 2030. Our GMP Publications will satisfy the starting memberships. We are seeking a Business Partner, eager to become the world’s leading authority in the regulated industry, in what will be a $30 million plus, annual recuring revenue.
The cost for the annual recuring membership starts at $29.95 for Consumers (globally affordable), and $49.95 for Business Professionals. Sign-ups will begin January 1st, 2026. The cost may appear low; however, we are expecting 1-5 million annual recuring subscription which is significant.
This association website is going to be the first A.I. Member driven dashboard news feed targeting members’ personalized programs requirements and needs of our subscribers based upon their profile requirements. All automated for a ‘Low’ subscription cost.
We are seeking a ‘Partner’ who would like to share in ownership, development, and management of the Association. Preferably a foreign partnership that would like to own 49% of Medical Industry News Feeds. In addition, owners will get a percentage of Business sales included on the www.thequalitygroups.com website.
In addition, we will be launching the FDA Medical Network News Television Channel and Steaming services at FDA.TV launching 2nd quarter 2026.
Let me know what you think, as we would be interested in your opinions and comments.